<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for http://feeds.benzinga.com/benzinga</title><link>http://feeds.benzinga.com/benzinga</link><description>Individual feed output.</description><lastBuildDate>Fri, 23 Jan 2026 17:10:43 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>What's Going On With Super League Stock?</title><link>https://www.benzinga.com/trading-ideas/movers/26/01/50109901/whats-going-on-with-super-league-stock</link><image_url>https://cdn.benzinga.com/files/images/story/2026/01/23/Advertising---Testimonial-Photo-Of-Marke.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Super League Enterprise, Inc. (NASDAQ:SLE) shares are down on Friday after the advertising company announced an exclusive partnership with Solsten to ...</description><pubDate>Fri, 23 Jan 2026 20:06:53 GMT</pubDate></item><item><title>What Analysts Are Saying About Banc of California Stock</title><link>https://www.benzinga.com/insights/analyst-ratings/26/01/50109698/what-analysts-are-saying-about-banc-of-california-stock</link><image_url>https://cdn.benzinga.com/files/images/story/2025/11/06/analyst_ratings_6.jpg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Latest Ratings for BANC Date Firm Action From To Jan 2022 Raymond James Maintains Outperform Oct 2021 Raymond James Maintains Outperform Jul 2021 Raym...</description><pubDate>Fri, 23 Jan 2026 20:01:13 GMT</pubDate></item><item><title>A Glimpse Into The Expert Outlook On Jacobs Solutions Through 9 Analysts</title><link>https://www.benzinga.com/insights/analyst-ratings/26/01/50109688/a-glimpse-into-the-expert-outlook-on-jacobs-solutions-through-9-analysts</link><image_url>https://cdn.benzinga.com/files/images/story/2025/11/06/analyst_ratings_6.jpg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Latest Ratings for J Date Firm Action From To Feb 2022 Credit Suisse Maintains Outperform Dec 2021 Barclays Maintains Overweight Nov 2021 Citigroup Ma...</description><pubDate>Fri, 23 Jan 2026 20:01:04 GMT</pubDate></item><item><title>What Analysts Are Saying About Neurocrine Biosciences Stock</title><link>https://www.benzinga.com/insights/analyst-ratings/26/01/50109678/what-analysts-are-saying-about-neurocrine-biosciences-stock</link><image_url>https://cdn.benzinga.com/files/images/story/2025/11/06/analyst_ratings_3.jpg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Latest Ratings for NBIX Date Firm Action From To Mar 2022 Piper Sandler Downgrades Overweight Neutral Feb 2022 Goldman Sachs Upgrades Neutral Buy Feb ...</description><pubDate>Fri, 23 Jan 2026 20:00:56 GMT</pubDate></item><item><title>Oklo's Options Frenzy: What You Need to Know</title><link>https://www.benzinga.com/insights/options/26/01/50109675/oklos-options-frenzy-what-you-need-to-know</link><image_url>https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>read more</description><pubDate>Fri, 23 Jan 2026 20:00:53 GMT</pubDate></item></channel></rss>